Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The innate immune system in demyelinating disease.
White matter disease: 'Bright spotty lesions'-a novel NMO-specific MRI feature?
[Subcutaneous immunoglobulin. Treatment in chronic inflammatory demyelinating polyradiculo-neuropathy].
Quantitative evaluation of CXCL8 and its receptors (CXCR1 and CXCR2) gene expression in Iranian patients with multiple sclerosis.
[Pegylated interferon beta 1a : A new therapy option for treatment of relapsing-remitting multiple sclerosis].
Comment on 'Fingolimod to treat severe MS after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?' Maillart et al.
Claudin Proteins And Neuronal Function.
Headache in multiple sclerosis and autoimmune disorders.
Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review.
Natalizumab treatment for multiple sclerosis.
Is the incidence of optic neuritis rising? Evidence from an epidemiological study in Barcelona (Spain), 2008-2012.
Respiratory muscle training for respiratory deficits in neurodegenerative disorders: a systematic review.
The influence of executive functions and memory on self-generation benefit in persons with multiple sclerosis.
Strategies used by individuals with multiple sclerosis and with mild disability to maintain dynamic stability during a steering task.
Evolution of longitudinally extensive transverse myelitis in an aquaporin-4 IgG-positive patient.
Knowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon beta.
Multiple sclerosis and pregnancy: therapeutic considerations.
Genetic and infectious profiles influence cerebrospinal fluid IgG abnormality in Japanese multiple sclerosis patients.
CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome.
A Fresh Look at the Potential Mechanisms of Progressive Muscle Relaxation Therapy on Depression in Female Patients With Multiple Sclerosis.
Sphingosine 1-Phosphate Receptor 1 as a Useful Target for Treatment of Multiple Sclerosis.
Mitochondrial DNA sequence variation in multiple sclerosis.
Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci.
Longitudinally extensive varicella-zoster virus myelitis in a multiple sclerosis patient.
Ascl1/Mash1 Promotes Brain Oligodendrogenesis during Myelination and Remyelination.
Pages
« first
‹ previous
…
405
406
407
408
409
410
411
412
413
…
next ›
last »